Dapirolizumab

1 Cited Publications
Avis client

Based on 1 publication(s) in Google Scholar

Dapirolizumab is a PEG-free antigen-binding (Fab') fragment that binds CD40L (CD154) and lacks a functional Fc domain. Dapirolizumab inhibits CD40L-dependent immune responses without causing thrombotic complications and can be used in research related to systemic lupus erythematosus.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté : 99.66%
  • CAS No.: 2235418-88-7
  • Masse moléculaire:145.5 kDa
  • Stockage:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00